RxDoctor Payments Data

Tzivya Kownat

Psychiatric/Mental Health · Lakewood, NJNPI 1992077630

Payments from drug & device makers

$3,346in general payments, 2019–2025

Across 257 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$711
  • Johnson & Johnson$545
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$491
  • AbbVie$406
  • Otsuka America Pharmaceutical, Inc.$329
  • Alkermes, Inc.$314
  • plus $550 from 7 others

What the payments were for

  • Food & beverage$3,20096%
  • Education$1464%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,346 in reported general payments places this provider in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.

See all psychiatric/mental health providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate155$536,105
Abilify MaintenaAripiprazole89$301,683
Invega TrinzaPaliperidone Palmitate25$211,392
AristadaAripiprazole Lauroxil52$209,250
VivitrolNaltrexone Microspheres111$201,440
VraylarCariprazine Hcl68$134,400
IngrezzaValbenazine Tosylate17$133,878
ZenpepLipase/Protease/Amylase16$131,040
CaplytaLumateperone Tosylate42$88,324
JubliaEfinaconazole23$80,794
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$73,445
UzedyRisperidone19$64,808
RexultiBrexpiprazole40$61,543
XiidraLifitegrast27$49,985
PerserisRisperidone16$48,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$545$747,497180 claims
Alkermes, Inc.Aristada, Vivitrol$314$410,690163 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$329$363,226129 claims
AbbVieVraylar, Restasis$406$165,96490 claims
Neurocrine Biosciences, Inc.Ingrezza$203$133,87817 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$491$88,32442 claims
Teva Pharmaceuticals USA, Inc.Uzedy$711$64,80819 claims
Indivior Inc.Perseris$193$48,00816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,212 psychiatric/mental health providers in New Jersey.

Other psychiatric/mental health in Lakewood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →